Melatonin and sleep: Exploring its role in regulating the circadian rhythm and sleep-wake cycle
Abstract
Sleep is a vital physiological process essential for maintaining overall health, supporting cellular repair, immune regulation, and cognitive functions. Sleep disruptions are associated with adverse health outcomes, including cardiovascular diseases, metabolic disorders, and impaired mental health. Sleep regulation is orchestrated by the circadian rhythm and homeostatic sleep drive, with melatonin-a neurohormone secreted by the pineal gland-playing a pivotal role in modulating these processes. Melatonin synthesis follows a biochemical pathway, converting serotonin to melatonin through key enzymes, AANAT and HIOMT, under circadian control. The suprachiasmatic nucleus (SCN) governs its secretion via light-responsive pathways, with light exposure inhibiting and darkness stimulating melatonin production. Acting through MT1 and MT2 receptors in the SCN and other brain regions, melatonin facilitates sleep onset, circadian rhythm alignment, and sleep maintenance while exerting antioxidant, anti-inflammatory, and chronobiotic effects. Exogenous melatonin has emerged as a therapeutic agent for managing sleep disorders, such as circadian rhythm sleep-wake disorders, jet lag, and insomnia. Its chronobiotic properties enable circadian phase-shifting, aligning sleep-wake cycles with environmental cues. Despite its growing use, questions remain regarding optimal dosing and long-term safety. This review delves into the physiology of melatonin, its synthesis, regulation, and mechanisms of…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.